Saturday, 21 December 2024
  
Login

Australia's most trusted
source of pharma news

Saturday, 21 December 2024
News

He's back: Ex-GM wins CEO role

Posted 18 December 2024 PM

Prescient Therapeutics has landed high-flyer James McDonnell to head the company, with McDonnell stepping into the CEO role on 20 January next year.

McDonnell has over 25 years experience in the global pharmaceutical industry, with significant involvement in blood disorders and hematological malignancies, which matches Prescient's lead candidate PTX-100, which is in Phase 1b trials for T cell lymphomas.

To see the whole article, please login

Popular

Who got booted to the May meet?
Best company Christmas gift is...
First out the door in '25?
He's back: Ex-GM wins CEO role
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home